You'll see deal comparisons for Trovax. This deal could now come at any time. On 8th Dec OXB confirmed that 4no potential partners had passed due diligence and were dscussing deal terms. OXB were progressing this 'expeditiosly'.
Look about and you'll also see bio's are quickly being bought out by the majors, OXB not only has Trovax but Prosavin and Retinostat which are likely to acheve equally large deal terms when their time comes.
No doubt you can still buy in for short-term gains, or stick it out for a year for the bigger gains........if OXB still independent.
Oh, and i've not even bothered mentioning Lentivectors, licensed by all the majors for research purposes and possibly giving OXB a platform technology with a finger in every pie for a long time too come!